Korean Circulation Journal

  • 제47권5호
  • /
  • Pages.786-793
  • /
  • 2017
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

How Long Can the Next Intervention Be Delayed after Balloon Dilatation of Homograft in the Pulmonary Position?

  • Jeong, Hye-In (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Song, Jinyoung (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Eun Young (Department of Pediatrics, Sejong General Hospital) ;
  • Kim, Sung Ho (Department of Pediatrics, Sejong General Hospital) ;
  • Huh, Jun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, I-Seok (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Ji Hyuk (Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jun, Tae Gook (Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2017.02.28
  • 심사 : 2017.05.31
  • 발행 : 2017.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Background and Objectives: We investigated the effectiveness of balloon dilatation of homograft conduits in the pulmonary position in delaying surgical replacement. Subjects and Methods: We reviewed the medical records of patients who underwent balloon dilatation of their homograft in the pulmonary position from 2001 to 2015. The pressure gradient and ratio of right ventricular pressure were measured before and after the procedure. The primary goal of this study was to evaluate the parameters associated with the interval to next surgical or catheter intervention. Results: Twenty-eight balloon dilations were performed in 26 patients. The median ages of patients with homograft insertion and balloon dilatation were 20.3 months and 4.5 years, respectively. The origins of the homografts were the aorta (53.6%), pulmonary artery (32.1%), and femoral vein (14.3%). The median interval after conduit implantation was 26.7 months. The mean ratio of balloon to graft size was 0.87. The pressure gradient through the homograft and the ratio of right ventricle to aorta pressure were significantly improved after balloon dilatation (p<0.001). There were no adverse events during the procedure with the exception of one case of balloon rupture. The median interval to next intervention was 12.9 months. The median interval of freedom from re-intervention was 16.6 months. Cox proportional hazards analysis revealed that the interval of freedom from re-intervention differed only according to origin of the homograft (p=0.032), with the pulmonary artery having the longest interval of freedom from re-intervention (p=0.043). Conclusion: Balloon dilatation of homografts in the pulmonary position can be safely performed, and homografts of the pulmonary artery are associated with a longer interval to re-intervention.

키워드

참고문헌

  1. Ross DN, Somerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet 1966;2:1446-7.
  2. Tatebe S, Nagakura S, Boyle EM Jr, Duncan BW. Right ventricle to pulmonary artery reconstruction using a valved homograft. Circ J 2003;67:906-12. https://doi.org/10.1253/circj.67.906
  3. Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006;27:1478-84.
  4. Saravalli OA, Somerville J, Jefferson KE. Calcification of aortic homografts used for reconstruction of the right ventricular outflow tract. J Thorac Cardiovasc Surg 1980;80:909-20.
  5. Yankah AC, Alexi-Meskhishvili V, Weng Y, Schorn K, Lange PE, Hetzer R. Accelerated degeneration of allografts in the first two years of life. Ann Thorac Surg 1995;60:S71-6. https://doi.org/10.1016/0003-4975(95)00289-W
  6. Sanatani S, Potts JE, Human DG, Sandor GG, Patterson MW, Gordon Culham JA. Balloon angioplasty of right ventricular outflow tract conduits. Pediatr Cardiol 2001;22:228-32. https://doi.org/10.1007/s002460010209
  7. Bertels RA, Dalinghaus M, Witsenburg M, et al. Results of balloon dilatation of stenotic homografts in pulmonary position in children and young adults. Cardiol Young 2012;22:589-95. https://doi.org/10.1017/S1047951112000157
  8. Hainstock MR, Marshall AC, Lock JE, McElhinney DB. Angioplasty of obstructed homograft conduits in the right ventricular outflow tract with ultra-noncompliant balloons: assessment of therapeutic efficacy and conduit tears. Circ Cardiovasc Interv 2013;6:671-9. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000073
  9. Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation 2006;113:2598-605. https://doi.org/10.1161/CIRCULATIONAHA.105.607127
  10. Powell AJ, Lock JE, Keane JF, Perry SB. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results. Circulation 1995;92:3282-8. https://doi.org/10.1161/01.CIR.92.11.3282
  11. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-16. https://doi.org/10.1161/CIRCULATIONAHA.109.921692
  12. Sreeram N, Hutter P, Silove E. Sustained high pressure double balloon angioplasty of calcified conduits. Heart 1999;81:162-5. https://doi.org/10.1136/hrt.81.2.162
  13. Bohm JO, Botha CA, Horke A, et al. Is the Ross operation still an acceptable option in children and adolescents? Ann Thorac Surg 2006;82:940-7. https://doi.org/10.1016/j.athoracsur.2006.04.086
  14. Lloyd TR, Marvin WJ Jr, Mahoney LT, Lauer RM. Balloon dilation valvuloplasty of bioprosthetic valves in extracardiac conduits. Am Heart J 1987;114:268-74. https://doi.org/10.1016/0002-8703(87)90489-3
  15. Waldman JD, Schoen FJ, Kirkpatrick SE, Mathewson JW, George L, Lamberti JJ. Balloon dilatation of porcine bioprosthetic valves in the pulmonary position. Circulation 1987;76:109-14. https://doi.org/10.1161/01.CIR.76.1.109
  16. LeBlanc JG, Russell JL, Sett SS, Potts JE. Intermediate follow-up of right ventricular outflow tract reconstruction with allograft conduits. Ann Thorac Surg 1998;66:S174-8. https://doi.org/10.1016/S0003-4975(98)01032-7
  17. Albert JD, Bishop DA, Fullerton DA, Campbell DN, Clarke DR. Conduit reconstruction of the right ventricular outflow tract. Lessons learned in a twelve-year experience. J Thorac Cardiovasc Surg 1993;106:228-35.
  18. McGrath LB, Gonzalez-Lavin L, Graf D. Pulmonary homograft implantation for ventricular outflow tract reconstruction: early phase results. Ann Thorac Surg 1988;45:273-7. https://doi.org/10.1016/S0003-4975(10)62461-7
  19. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 1995;109:509-17. https://doi.org/10.1016/S0022-5223(95)70282-2
  20. Zeevi B, Keane JF, Perry SB, Lock JE. Balloon dilation of postoperative right ventricular outflow obstructions. J Am Coll Cardiol 1989;14:401-8. https://doi.org/10.1016/0735-1097(89)90193-9
  21. Aggarwal S, Garekar S, Forbes TJ, Turner DR. Is stent placement effective for palliation of right ventricle to pulmonary artery conduit stenosis? J Am Coll Cardiol 2007;49:480-4. https://doi.org/10.1016/j.jacc.2006.09.037